Observational studyMedicine2026
Evaluation of the relationship between ABO and Rh blood groups and clinical course in acute pancreatitis: A retrospective observational cohort study.
Observational study in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early identification of patients at risk for severe acute pancreatitis (AP) remains a major clinical challenge. Although several clinical scores and inflammatory markers are used for risk stratification, their predictive performance is variable. ABO and Rh blood groups are fixed biological characteristics that have been associated with inflammatory and thrombotic conditions; however, their potential role in predicting the clinical course of acute pancreatitis remains unclear. This retrospective observational study included 512 patients hospitalized with a diagnosis of acute pancreatitis between January 2018 and May 2025. Diagnosis and disease severity were classified according to the Revised Atlanta Classification. ABO and Rh blood group information, along with demographic, laboratory, and clinical data, was obtained from the institutional hospital database. Patients were categorized as having mild or non-mild acute pancreatitis, the latter comprising moderately severe and severe disease. Statistical analyses were performed using the Chi-square test and the Mann-Whitney U test. Non-mild acute pancreatitis was observed in 17.8% of patients. The frequency of non-mild disease was significantly higher among individuals with blood group O compared with other ABO blood groups (24.5% vs 14.3%, P = .033). No significant association was identified between Rh factor and disease severity (P = .88). Male sex, obesity (body mass index ≥ 30 kg/m2), and elevated C-reactive protein levels (>150 mg/L) at admission were significantly associated with a more severe disease course. Leukocyte count, hematocrit, and peak C-reactive protein levels were higher in the non-mild group, whereas amylase and lipase levels did not differ significantly between severity categories. Blood group O was associated with a higher prevalence of non-mild acute pancreatitis in this cohort. While ABO blood group alone should not be considered a standalone prognostic marker, its integration with established clinical and inflammatory parameters may contribute to early risk stratification. Further multicenter prospective studies are warranted to clarify the role of ABO blood groups in the clinical course of acute pancreatitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.